CLINICAL_TRIALS
trial_result
· 2012-03-29
Clinical Trial Update: Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer [Phase 2]
Summary
This update reports the results of a Phase 2 trial evaluating amifostine to protect the rectum during external beam radiotherapy for prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-03-29